Prion Disease: Chemotherapeutic Strategies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|12|2|144-160

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.12, Iss.2, 2012-04, pp. : 144-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon   Ferrante Robert J  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies inhibit prion disease

By  

Inpharma, Vol. 1, Iss. 1380, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Telomerase - strategies to exploit an important chemotherapeutic target

By Fletcher Terace M  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 363-378

Informa Healthcare

Access to resources Recommend Favorite

Role of Genomics-Based Strategies in Overcoming Chemotherapeutic Resistance

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 5, 2004-10 ,pp. : 471-480

Bentham Science Publishers

Access to resources Recommend Favorite

New Chemotherapeutic Strategies Against Malaria, Leishmaniasis and Trypanosomiases

By  

Current Medicinal Chemistry, Vol. 20, Iss. 4, 2013-02 ,pp. : 502-526

Bentham Science Publishers

Access to resources Recommend Favorite